The Effects of Antidepressants and Quetiapine on Heart Rate Variability

Abstract

Introduction: The autonomic effects of antidepressants and quetiapine on heart rate variability (HRV) are inconsistent based on past studies. The aim of this study was to explore their influence on the HRV of psychiatric patients without psychotic symptoms.

Methods: A total of 94 patients with depression, anxiety, or somatic symptoms, were recruited into this study. Based on their medication, 4 groups were identified: the no antidepressant group (n=19), the SSRI group (using sertraline or escitalopram, n=53), the other antidepressants group (using venlafaxine or mirtazapine, n=9), and the augmentation group (AG, using an antidepressant+quetiapine, n=13). The HRV of the 4 groups were compared. The correlations between HRV and the medication(s) used were clarified.

Results: Among the 4 groups, the AG had the lowest HRV with its total power (TP), very low frequency power (VLF) and low frequency power (LF) of HRV being significantly different from those of the other groups. Age and using quetiapine were found to be negatively correlated with TP, VLF and LF. With this study group, the autonomic effects of antidepressants were found not to be significant.

Discussion: Among psychiatric patients without psychotic symptoms, quetiapine causes an overt decrease in HRV.

Key words

heart rate variability - autonomic nervous system - antidepressants - quetiapine

• References

• 1 Servant D, Logier R, Mouster Y et al. Heart rate variability. Applications in psychiatry. L’Encephale 2009; 35: 423-428
• 2 Lo Turco G, Grimaldi Di Terresena L. Spectral analysis of Heart Rate Variability in psychiatric patients: autonomic nervous system evaluation in psychotic, anxiety and depressive disorders. Rivista di psichiatria 2012; 47: 139-148
• 3 Yeragani VK. Heart rate and blood pressure variability: implications for psychiatric research. Neuropsychobiology 1995; 32: 182-191
• 4 [Anonymous]. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996; 93: 1043-1065
• 5 Kuo TB, Lin T, Yang CC et al. Effect of aging on gender differences in neural control of heart rate. Am J Physiol 1999; 277: H2233-H2239
• 6 Huang WL, Chang LR, Kuo TB et al. Impact of antipsychotics and anticholinergics on autonomic modulation in patients with schizophrenia. J Clin Psychopharmacol 2013; 33: 170-177
• 7 Udupa K, Thirthalli J, Sathyaprabha TN et al. Differential actions of antidepressant treatments on cardiac autonomic alterations in depression: A prospective comparison. Asian J Psychiatr 2011; 4: 100-106
• 8 Licht CM, de Geus EJ, van Dyck R et al. Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. Biol Psychiatry 2010; 68: 861-868
• 9 Kemp AH, Quintana DS, Gray MA et al. Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry 2010; 67: 1067-1074
• 10 Zimmermann-Viehoff F, Kuehl LK, Danker-Hopfe H et al. Antidepressants, autonomic function and mortality in patients with coronary heart disease: data from the Heart and Soul Study. Psychol Med 2014; 44: 2975-2984
• 11 Dinleyici EC, Kilic Z, Sahin S et al. Heart rate variability in children with tricyclic antidepressant intoxication. Cardiol Res Pract 2013; 2013: 196506
• 12 van Zyl LT, Hasegawa T, Nagata K. Effects of antidepressant treatment on heart rate variability in major depression: a quantitative review. Biopsychosoc Med 2008; 2: 12
• 13 Volkers AC, Tulen JH, van den Broek WW et al. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder. Pharmacopsychiatry 2004; 37: 18-25
• 14 Siepmann M, Krause S, Joraschky P et al. The effects of St John’s wort extract on heart rate variability, cognitive function and quantitative EEG: a comparison with amitriptyline and placebo in healthy men. Br J Clin Pharmacol 2002; 54: 277-282
• 15 Evans DL, Staab J, Ward H et al. Depression in the medically ill: management considerations. Depress Anxiety 1996; 4: 199-208
• 16 Rechlin T, Claus D, Weis M et al. Decreased heart rate variability parameters in amitriptyline treated depressed patients: biological and clinical significance. Eur Psychiatry 1995; 10: 189-194
• 17 Srinivasan K, Ashok MV, Vaz M et al. Effect of imipramine on linear and nonlinear measures of heart rate variability in children. Pediatr Cardiol 2004; 25: 20-25
• 18 Yeragani VK, Rao KA, Pohl R et al. Heart rate and QT variability in children with anxiety disorders: a preliminary report. Depress Anxiety 2001; 13: 72-77
• 19 Tulen JH, Bruijn JA, de Man KJ et al. Cardiovascular variability in major depressive disorder and effects of imipramine or mirtazapine (Org 3770). J Clin Psychopharmacol 1996; 16: 135-145
• 20 O’Regan C, Kenny RA, Cronin H et al. Antidepressants strongly influence the relationship between depression and heart rate variability: findings from The Irish Longitudinal Study on Ageing (TILDA). Psychol Med 2014; 1-14
• 21 Licht CM, de Geus EJ, van Dyck R et al. Association between anxiety disorders and heart rate variability in The Netherlands Study of Depress Anxiety (NESDA). Psychosom Med 2009; 71: 508-518
• 22 Licht CM, de Geus EJ, Seldenrijk A et al. Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension 2009; 53: 631-638
• 23 Koschke M, Boettger MK, Schulz S et al. Autonomy of autonomic dysfunction in major depression. Psychosom Med 2009; 71: 852-860
• 24 Bar KJ, Greiner W, Jochum T et al. The influence of major depression and its treatment on heart rate variability and pupillary light reflex parameters. J Affect Disord 2004; 82: 245-252
• 25 Roose SP, Laghrissi-Thode F, Kennedy JS et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. Jama 1998; 279: 287-291
• 26 Rechlin T, Weis M, Claus D. Heart rate variability in depressed patients and differential effects of paroxetine and amitriptyline on cardiovascular autonomic functions. Pharmacopsychiatry 1994; 27: 124-128
• 27 Blumenthal JA, Sherwood A, Babyak MA et al. Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Coll Cardiol 2012; 60: 1053-1063
• 28 Shea AK, Kamath MV, Fleming A et al. The effect of depression on heart rate variability during pregnancy. A naturalistic study. Clin Auton Res 2008; 18: 203-212
• 29 Glassman AH, Bigger JT, Gaffney M et al. Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement. Arch Gen Psychiatry 2007; 64: 1025-1031
• 30 Dai F, Lei Y, Chen JD. Inhibitory effects of desvenlafaxine on gastric slow waves, antral contractions, and gastric accommodation mediated via the sympathetic mechanism in dogs. Am J Physiol Gastrointest Liver Physiol 2011; 301: G707-G712
• 31 Terhardt J, Lederbogen F, Feuerhack A et al. Heart rate variability during antidepressant treatment with venlafaxine and mirtazapine. Clin Neuropharmacol 2013; 36: 198-202
• 32 Chang JS, Ha K, Yoon IY et al. Patterns of cardiorespiratory coordination in young women with recurrent major depressive disorder treated with escitalopram or venlafaxine. Prog Neuropsychopharmacol Biol Psychiatry 2012; 39: 136-142
• 33 Agelink MW, Majewski T, Wurthmann C et al. Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine. J Clin Psychopharmacol 2001; 21: 8-13
• 34 Kim JH, Yi SH, Yoo CS et al. Heart rate dynamics and their relationship to psychotic symptom severity in clozapine-treated schizophrenic subjects. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 371-378
• 35 Mueck-Weymann M, Rechlin T, Ehrengut F et al. Effects of olanzapine and clozapine upon pulse rate variability. Depress Anxiety 2002; 16: 93-99
• 36 Eschweiler GW, Bartels M, Langle G et al. Heart-rate variability (HRV) in the ECG trace of routine EEGs: fast monitoring for the anticholinergic effects of clozapine and olanzapine?. Pharmacopsychiatry 2002; 35: 96-100
• 37 Malaspina D, Dalack G, Leitman D et al. Low heart rate variability is not caused by typical neuroleptics in schizophrenia patients. CNS Spectr 2002; 7: 53-57
• 38 Hempel RJ, Tulen JH, van Beveren NJ et al. Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia. J Psychopharmacol 2009; 23: 697-707
• 39 Wang YC, Yang CC, Bai YM et al. Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine. 3-month follow-up. Neuropsychobiology 2008; 57: 200-205
• 40 Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 64: 258-266
• 41 Lee S, Creed FH, Ma YL et al. Somatic symptom burden and health anxiety in the population and their correlates. J Psychosom Res 2015; 78: 71-76
• 42 Lucock MP, Morley S. The health anxiety questionnaire. Brit J Health Psych 1996; 1: 137-150
• 43 Beck AT, Steer RA, Ball R et al. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 1996; 67: 588-597
• 44 Steer RA, Rissmiller DJ, Ranieri WF et al. Structure of the computer-assisted Beck Anxiety Inventory with psychiatric inpatients. J Pers Assess 1993; 60: 532-542
• 45 Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken) 2011; 63 (Suppl. 11) S467-S472
• 46 Taylor JA, Carr DL, Myers CW et al. Mechanisms underlying very-low-frequency RR-interval oscillations in humans. Circulation 1998; 98: 547-555
• 47 Jain FA, Cook IA, Leuchter AF et al. Heart rate variability and treatment outcome in major depression: a pilot study. Int J Psychophysiol 2014; 93: 204-210
• 48 Kemp AH, Brunoni AR, Santos IS et al. Effects of depression, anxiety, comorbidity, and antidepressants on resting-state heart rate and its variability: an ELSA-Brasil cohort baseline study. Am J Psychiatry 2014; 171: 1328-1334
• 49 Agelink MW, Majewski TB, Andrich J et al. Short-term effects of intravenous benzodiazepines on autonomic neurocardiac regulation in humans: a comparison between midazolam, diazepam, and lorazepam. Crit Care Med 2002; 30: 997-1006
• 50 Unoki T, Grap MJ, Sessler CN et al. Autonomic nervous system function and depth of sedation in adults receiving mechanical ventilation. American journal of critical care: an official publication. Am J Crit Care 2009; 18: 42-50 quiz 51